Ligand Pharmaceuticals reported $4.85M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Amgen USD 1.43B 298M Jun/2025
Arrowhead Research USD -175241000 545.69M Jun/2025
Baxter International USD 91M 35M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Glaxosmithkline GBP 1.44B 1.03B Jun/2025
Insmed USD -321686000 65.1M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
Ligand Pharmaceuticals USD 4.85M 47.3M Jun/2025
MacroGenics USD -36250000 20.83M Jun/2025
Merck USD 4.43B 652M Jun/2025
Pacira USD -4847000 9.66M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Veracyte USD -980000 8.03M Jun/2025